Overview
Scantox performs comprehensive ICH‑aligned stability studies to establish shelf life and define storage conditions for investigational and commercial products.
We conduct long‑term, intermediate, and accelerated stability studies across all ICH climatic zones, evaluating appearance, assay, degradation products, dissolution, and other critical attributes.
Our GMP‑compliant chambers are continuously monitored, ensuring controlled temperature and humidity profiles.
Stability protocols and reporting follow ICH Q1A (R2) requirements, supporting clinical release, regulatory submissions, and lifecycle management.
Combined with integrated QC analytics, our stability programs deliver high‑quality data for decision‑making and global compliance.
Scantox Can Help
At Scantox, we’re committed to being your trusted partner in preclinical formulation. Our extensive experience and structured approaches ensure your API is formulated for optimal performance in preclinical studies. We help you mitigate risks, save time, and move confidently toward First-In-Human studies.
